Healthcare Professional Portal

Return to portal
Register
Register

Click here for prescribing information and adverse event reporting information (hosted externally).

Our Services
PI & AE

QUVIVIQ™ is indicated for the treatment of adult patients with insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.1

Gain access to resources on chronic insomnia

Subscribe for updates from us on the management of chronic insomnia, expert speaker videos from congresses and other events, as well as useful infographics, patient support items, and more!

Click here to go back
Click here to go back
Register and stay up to date with the latest news about QUVIVIQ™, chronic insomnia and sleep science. By registering and ticking this box you are confirming you have read and agreed to the Informed Consent and Privacy Policy and you herewith consent to the processing of your personal data in line therewith.

Insomnia Conversation Starter

Discuss key domains to uncover your patients’ insomnia

Hands holding the 'How well do you sleep?' patient questionnaire, a conversation starter on chronic insomnia
Click here to go back
Click here to go back

Black triangle symbol: this medicine is subject to additional monitoring This medicine is subject to additional monitoring.

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/. Adverse events should also be reported to Idorsia at ds.safety.uk@idorsia.com.

This information is intended for UK healthcare professionals.

References

  1. QUVIVIQ™ (daridorexant) Summary of Product Characteristics

UK-DA-00922 | Last updated: July 2025

Copyright © 2026 Idorsia Pharmaceuticals Ltd
Create an account
Idorsia logo
Access our in-depth e-learning resources on chronic insomnia
Title *
First name *
Last name *
Professional email *
Password *
Specialty *
Professional registration number *

Select below to keep informed of further resources:

You already have an account? 

Sign in

Gain access to resources on chronic insomnia​

Register to get access to:

  • Insightful videos
  • Patient resources
  • E-Learning programme
  • And details about us and our offerings
Hands holding the 'How well do you sleep?' patient questionnaire, a conversation starter on chronic insomnia
Welcome back!
Idorsia logo

Please complete the form below to sign in.

You don’t have an account? 

Sign up

Table of Contents

Idorsia logo

You are now entering
pro.idorsia.uk

You are being redirected to our partner’s website pro.idorsia.uk.       The content of this website contains promotional information for UK healthcare professionals and is managed by
Idorsia Pharmaceuticals UK Ltd.

Enter website

UK-DA-01463 | Date of preparation: April 2026

Copyright ©2026 Idorsia Pharmaceuticals Ltd

Your resource is ready to download.

Providing your details is optional, but enables us to share future updates and resources that may be of interest to you.

Download will open in a new window.

Register and stay up to date with the latest news about QUVIVIQ™▼ (daridorexant), chronic insomnia and sleep science. By registering and ticking this box you are confirming you have read and agreed to the Informed Consent and Privacy Policy and you herewith consent to the processing of your personal data in line therewith.

Idorsia logo

You are now leaving
pro.idorsia.uk

You will now be redirected to an independent third party site that is maintained outside of this website, where all Idorsia Pharmaceuticals Ltd UK’s medicines can be found: the electronic Medicines Compendium (eMC)

Continue to medicines.org.uk

UK-DA-00439 | Date of preparation: February 2026

Copyright ©2026 Idorsia Pharmaceuticals Ltd
Idorsia logo

You are now leaving
pro.idorsia.uk

You are now leaving pro.idorsia.uk. You will now be redirected to an independent third-party site that is maintained outside of this website.

You are now leaving pro.idorsia.uk. The linked website provides helpful information if you are having trouble sleeping. It is neither owned or controlled by Idorsia Pharmaceuticals Ltd. Idorsia accepts no responsibility for the content or services of the linked site.

Cancel
Go to link

UK-DA-00445 | Date of preparation: Februrary 2026

Copyright ©2026 Idorsia Pharmaceuticals Ltd

Confirming your contact information and preferences means that you agree that we, Idorsia, manage your personal data in our Client Relationship Management system to document, customise, plan, and conduct our interactions with you and, to analyse and segment your interactions, interests, preferences, and scientific activities in order to interact with you in a way we think is most relevant to you.

It also means that you agree that we will send you Idorsia standard or personalised medical, company or product related information and material via email based on your choices and on what we think is of interest to you. You further consent that we process your personal data for this.

For more information about us, our processing of your personal data and your rights, please see our Privacy Notice.

Idorsia logo

Welcome to the Idorsia UK
Healthcare Professional Portal

This information is intended for UK Healthcare Professionals only.

By entering this site you are confirming that you are a UK Healthcare Professional.

I am a UK healthcare professional
I am a member of the public

UK-DA-00217 | Date of preparation: February 2026

Copyright ©2026 Idorsia Pharmaceuticals Ltd